Boston Scientific agreed to buy Criterion Medical in July 2018, a firm that created a single-shot cryoablation platform for the treatment of atrial fibrillation. The former company will be able to provide geothermal and radiofrequency (RF) single-shot, balloon-based ablation therapies as a result of the transaction.
V9bett Bet
Shbetvndcom3
Harris Tennant
Sunwin
U88
Khoa Học Tv
Haugaard Choate
99win
Paths Law Firm
Dt68